---
figid: PMC11020901__pntd.0012075.g001
pmcid: PMC11020901
image_filename: pntd.0012075.g001.jpg
figure_link: /pmc/articles/PMC11020901/figure/pntd.0012075.g001/
number: Fig 1
figure_title: Chikungunya vaccine development to introduction pathway
caption: Schematic showing the vaccine development process for the chikungunya vaccine
  alongside stages of licensure and evidence-based recommendations for policy making
  decisions. WHO–World Health Organization; MoH–Ministry of Health, NRA—National Regulatory
  Agencies, SAGE–Strategic Advisory Group of Experts, EPI–Expanded Program for Immunization,
  NITAG–National Immunization Technical Advisory Group, PQ- Pre-qualification.
article_title: 'Programmatic considerations and evidence gaps for chikungunya vaccine
  introduction in countries at risk of chikungunya outbreaks: Stakeholder analysis.'
citation: Megan Auzenbergs, et al. PLoS Negl Trop Dis. 2024 Apr;18(4):e0012075.
year: '2024'

doi: 10.1371/journal.pntd.0012075
journal_title: PLOS Neglected Tropical Diseases
journal_nlm_ta: PLoS Negl Trop Dis
publisher_name: Public Library of Science

keywords:
---
